ISPOR Asia Pacific 2020 Conference
ISPOR Asia Pacific 2020—a health economics and outcomes research (HEOR) conference themed “The Next Generation Healthcare in Asia Pacific will take place from 12 -15 September.
The confrence will be an opportunity for delegates to learn about HEOR’s role in precision medicine, patient involvement in healthcare decision-making, innovative high-cost interventions, and many other important issues. With over 1000 presentations featured, the conference represents your an opportunity to learn, engage, and network with the leading experts and key opinion leaders in the global HEOR community. will include more than 1000 presentations on topics such as real-world evidence, economic evaluation, clinical outcomes assessment, the use of health policy in decision-making, health technology assessment, and many more.
The conference will convene more than 1800 key global healthcare leaders and experts from around the region and will feature many opportunities to learn, engage, and network through sessions, meetings, receptions, discussion forums, and roundtables. Join us in Seoul to learn about the state-of-the-art in health economics and outcomes research (HEOR) and how new trends are impacting critical health policies in the Asia Pacific region.
The ISPOR scope and sphere of influence includes the international HEOR community of global leaders, policy makers, regulators, researchers, academicians, payers, patients, and patient groups. This multistakeholder group is invested in using science and research to make better healthcare decisions. The diversity in work environments and international scope of attendance provide excellent networking opportunities and stimulating discussions and debate.
Submit your Abstracts – Deadline is 11 March 2020
Theme-related content submissions are encouraged for the Conference, such as: strategies for evidence generation; communication and translation for improvement of patient-centered care; HEOR research and applications related to precision medicine; research and experiences with patient and public involvement in evidence strategy; the health technology assessment process and/or healthcare decision making; studies and experiences outlining novel approaches for healthcare financing and management by using HEOR.
Over 1000 presentations featured on a broad range of HEOR topics including but not limited to economic evaluation, real world evidence, evidence-informed policy and decision making, HTA, clinical outcomes assessment, medical devices, machine learning and AI, digital health, patient-reported outcomes, rare diseases and much more.
- Advancing Precision Medicines in Asia Pacific: Progress, Opportunities, and Challenges
- Patient and Public Involvement in HTA and Health Policy – Global Experiences and Lessons Learned
- Innovative Approaches to Pricing, Value Assessment, and Patient Access to High Cost Interventions
There are 18 short courses featured in Seoul, including 6 NEW Short Courses:
- Study Design with Real-World Data
- Health Technology Assessment for Rare Diseases
- Access & Value Assessment of Medical Devices
- Introduction to Machine Learning in Healthcare
- Adapting Cost Effectiveness Models across Countries
- Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications
- Reimbursement Systems for Pharmaceuticals in Asia Pacific
As the leading HEOR Conference in region, ISPOR Asia Pacific enjoys the support of numerous leading institutions in Asia Pacific including KaHTA (South Korea), Asian Institute of Management (Philippines), APACMed (Singapore), CDE (Taiwan), Centre for Applied Health Economics Griffith University (Australia), HTAsiaLink, CNHDRC (Mainland China), and many more!
See you in Seoul this September!